Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.1534 USD
−138.49 M USD
1.33 M USD
106.89 M
About Gritstone bio, Inc.
Sector
Industry
CEO
Andrew R. Allen
Website
Headquarters
Emeryville
Founded
2015
FIGI
BBG00LTQ2ZJ4
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GRTSQ is 0.0132 USD — it has increased by 7.32% in the past 24 hours. Watch Gritstone bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Gritstone bio, Inc. stocks are traded under the ticker GRTSQ.
GRTSQ stock has risen by 8.20% compared to the previous week, the month change is a −45.00% fall, over the last year Gritstone bio, Inc. has showed a −99.21% decrease.
GRTSQ reached its all-time high on Jan 20, 2021 with the price of 35.2000 USD, and its all-time low was 0.0029 USD and was reached on Dec 10, 2024. View more price dynamics on GRTSQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GRTSQ stock is 28.46% volatile and has beta coefficient of 1.95. Track Gritstone bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Gritstone bio, Inc. there?
Today Gritstone bio, Inc. has the market capitalization of 1.45 M, it has increased by 53.47% over the last week.
Yes, you can track Gritstone bio, Inc. financials in yearly and quarterly reports right on TradingView.
Gritstone bio, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
GRTSQ earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.17 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Gritstone bio, Inc. earnings.
Gritstone bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
GRTSQ net income for the last quarter is −23.40 M USD, while the quarter before that showed −40.38 M USD of net income which accounts for 42.07% change. Track more Gritstone bio, Inc. financial stats to get the full picture.
No, GRTSQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 231.00 employees. See our rating of the largest employees — is Gritstone bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gritstone bio, Inc. EBITDA is −143.35 M USD, and current EBITDA margin is −11.05 K%. See more stats in Gritstone bio, Inc. financial statements.
Like other stocks, GRTSQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gritstone bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gritstone bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gritstone bio, Inc. stock shows the sell signal. See more of Gritstone bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.